Boston Scientific Corp (BSP:B1SX34)
R$ 54.6 -2.7 (-4.71%) Market Cap: 316.51 Bil Enterprise Value: 379.44 Bil PE Ratio: 17.45 PB Ratio: 2.50 GF Score: 75/100

Boston Scientific Corp at Wells Fargo Healthcare Conference Transcript

Sep 10, 2026 / 12:00PM GMT
Lawrence Biegelsen
Wells Fargo Securities LLC - Analyst

Okay. All right. Good morning, everyone. Welcome to day three of the Wells Fargo Healthcare Conference. I'm Larry Biegelsen, the med tech analyst here. And it's my pleasure to host this fireside chat the management team from Boston Scientific. With us, we have Mike Mahoney, Chairman and CEO; and Dr. Ken Stein, Chief Medical Officer. Thanks so much for being here.

Michael Mahoney
Boston Scientific Corp - Chairman of the Board, President, Chief Executive Officer

Pleasure, Larry.

Ken Stein
Boston Scientific Corp - Senior Vice President, Global Chief Medical Officer

Thanks, Larry.

Lawrence Biegelsen
Wells Fargo Securities LLC - Analyst

I'd be remiss if I didn't say we also have Lauren Tengler, Head of Investor Relations, also with us.

Questions & Answers

Lawrence Biegelsen
Wells Fargo Securities LLC - Analyst

So Mike, let's start with the unfortunate

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot